Editorial
 108 DRUGS MORE UNDER DPCO   
 Wednesday, July 23, 2014 
 National Pharmaceutical Pricing Authority, early this month, brought 108 essential drugs more under the ambit of Drug Price Control Order, 2013 in addition to 348 drugs already under price control. 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]US FDA approves Targiniq ER to treat pain
17:20  [IST]Strides Arcolab Q1 revenue up by 14% to Rs. 260 crore
17:00  [IST]Taiho Pharma to invest US$ 30 mn in Remiges BioPharma Fund
16:30  [IST]Fortis Healthcare launches cancer institute at Mohali, Punjab
16:00  [IST]US FDA approves Gilead's Zydelig to treat relapsed chronic lymphocytic leukaemia
15:45  [IST]Eli Lilly' net earnings declines by 39% in Q2
more news >>
TOP NEWS
08:00  [IST]NPPA's recent price control order on 108 non-scheduled formulations to cover all companies
08:00  [IST]Telangana to develop international standard ‘Pharma city’ near Hyderabad
08:00  [IST]Gujarat govt to work with WHO to focus on neglected diseases
08:00  [IST]Himalaya Drug on advanced research path for cancer, psoriasis, diabetes: products to hit market from year-end
08:00  [IST]Thane division takes lead as ayurvedic drug manufacturing hub in Maharashtra
08:00  [IST]Health ministry bans manufacture, sale of controversial anti-depressant drug Deanxit
more news >>
YESTERDAY'S NEWS
18:00  [IST]US FDA clears Galmed's armachol IND to treat fatty liver disorders
17:50  [IST]Ranbaxy to market Cipher Pharma's isotretinoin capsules in Brazil
17:15  [IST]THCF signs MoU with Sri Ramachandra University for cancer care in children
17:00  [IST]Access Pharma's ProctiGard receives US FDA marketing approval
16:50  [IST]Glenmark net profit surges by 43.7% in Q1
16:10  [IST]Ayushakti’s first ‘Ayurvedic Franchise Centre’ launched in Mumbai
more news >>
INTERVIEW  
There is light at the end of the tunnel for the Indian clinical trial industry
Global clinical research organizations, leading international research centers and the bio pharma abroad are keen to conduct the human studies on the Indian patient population.
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Is the union health ministry's recent move to increase the number of drugs covered under the national list of essential medicines (NLEM) justified?
  
 
 
 

   
 
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
US FDA: REFUSAL
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
 
 
 
 
Copyright © 2010 Saffron Media Pvt. Ltd |